Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts

Biochimie

Volumn 85, Issue 3-4, 2003, Pages 439-448

  Sadeghlar, Farsaneh ^a   Remmel, Natascha ^a   Breiden, Bernadette ^a   Klingenstein, Ralf ^a   Schwarzmann, Guenter ^a   Sandhoff, Konrad ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Degradation; Forssman lipid; Ganglioside GM1; Sphingolipid activator protein

Indexed keywords

CARBON 14; FORSSMAN ANTIGEN; GANGLIOSIDE GM1; GANGLIOSIDE GM3; GLOBOTRIAOSYLCERAMIDE; GLYCOSPHINGOLIPID; LACTOSYLCERAMIDE; RECOMBINANT PROTEIN; SPHINGOLIPID ACTIVATOR PROTEIN; SPHINGOLIPID ACTIVATOR PROTEIN A; SPHINGOLIPID ACTIVATOR PROTEIN B; SPHINGOLIPID ACTIVATOR PROTEIN C; SPHINGOLIPID ACTIVATOR PROTEIN D; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; CATABOLISM; CONTROLLED STUDY; DRUG EXPOSURE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; ISOTOPE LABELING; PHYSIOLOGY; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN LOCALIZATION; SKIN FIBROBLAST;

EID: 0037518438     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(03)00020-8     Document Type: Article

References (42)

1. G. Schwarzmann, K. Sandhoff, Metabolism and intracellular transport of glycosphingolipids, Biochemistry 29 (1990) 10865-10871.
2. R.W. Ledeen, R.K. Yu, Gangliosides: Structure, isolation, and analysis, Methods Enzymol 83 (1982) 139-191.
3. G. Van Echten, K. Sandhoff, Ganglioside metabolism. Enzymology, topology, and regulation, J. Biol. Chem 268 (1993) 5341-5344.
4. K. Sandhoff, T. Kolter, Topology of glycosphingolipid degradation, Trends Cell Biol 6 (1996) 98-103 (Review).
5. T. Kolter, K. Sandhoff, Recent advances in the biochemistry of sphingolipidoses, Brain Pathol 8 (1998) 79-100 (Review).
6. W. Fürst, K. Sandhoff, Activator proteins and topology of lysosomal sphingolipid catabolism, Biochim. Biophys. Acta 1126 (1992) 1-16.
7. A. Klein, M. Henseler, C. Klein, K. Suzuki, K. Harzer, K. Sandhoff, Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo, Biochem. Biophys. Res. Commun 200 (1994) 1440-1448.
8. D.M. Swallow, I. Islam, M.F. Fox, H. Klima, U. Schepers, K. Sandhoff, Regional localization of the gene coding for the GM2 activator protein (GM2A) to chromosome 5q32-33 and confirmation of the assignment of GM2AP to chromosome 3, Ann. Hum. Genet 57 (1993) 187-193.
9. K. Inui, F.T. Kao, S. Fujibayashi, C. Jones, H.G. Morse, M.L. Law, D.A. Wenger, The gene coding for a sphingolipid activator protein, SAP-1, is on human chromosome 10, Hum. Genet. 69 (1985) 197-200.
10. K. Sandhoff, K. Harzer, W. Fürst, Sphingolipid activator protein, in: C. Sciver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The Metabolic and Molecular Bases of Inherited Disease, Seventh ed. McGraw-Hill, New York, 1995, pp. 2427-2441 (Review).
11. E. Conzelmann, K. Sandhoff, AB variant of infantile GM2 gangliosidosis: Deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2, Proc. Natl. Acad. Sci. USA 75 (1978) 3979-3983.
12. W. Schlote, K. Harzer, H. Christomanou, B.C. Paton, B. Kustermann-Kuhn, B. Schmid, J. Seeger, U. Beudt, I. Schuster, U. Langenbeck, Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study, Eur. J. Pediatr. 150 (1991) 584-591.
13. R.L. Stevens, A.L. Fluharty, H. Kihara, M.M. Kaback, L.J. Shapiro, B. Marsh, K. Sandhoff, G. Fischer, Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy, Am. J. Hum. Genet 33 (1981) 900-906.
14. H. Christomanou, A. Aignesberger, R.P. Linke, Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant, Biol. Chem. Hoppe-Seyler 367 (1986) 879-890.
15. H. Christomanou, A. Chabás, T. Pámpols, A. Guardiola, Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder, Klin. Wochenschr 67 (1989) 999-1003.
16. K. Harzer, B.C. Paton, A. Poulos, B. Kustermann-Kuhn, W. Roggendorf, T. Grisar, M. Popp, Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder, Eur. J. Pediatr 149 (1989) 31-39.
17. V. Bradová, F. Šmíd, B. Ulrich-Bott, W. Roggendorf, B.C. Paton, K. Harzer, Prosaposin deficiency: Further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease, Hum. Genet 92 (1993) 143-152.
18. N. Fujita, K. Suzuki, M.T. Vanier, B. Popko, N. Maeda, A. Klein, M. Henseler, K. Sandhoff, H. Nakayasu, Targeted disruption of the mouse sphingolipid activator protein gene: A complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids, Hum. Mol. Genet 5 (1996) 711-725.
19. A. Zschoche, W. Fürst, G. Schwarzmann, K. Sandhoff, Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis, Eur. J. Biochem 222 (1994) 83-90.
20. S. Morimoto, B.M. Martin, Y. Yamamoto, K.A. Kretz, J.S. O'Brien, Y. Kishimoto, Saposin A: Second cerebrosidase activator protein, Proc. Natl. Acad. Sci. USA 86 (1989) 3389-3393.
21. T. Linke, G. Wilkening, F. Sadeghlar, H. Mozcall, K. Bernardo, E. Schuchman, K. Sandhoff, Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins, J. Biol. Chem 276 (2000) 5760-5768.
22. M. Tayama, S. Soeda, Y. Kishimoto, B.M. Martin, J.W. Callahan, M. Hiraiwa, J.S. O'Brien, Effect of saposins on acid sphingomyelinase, Biochem. J 290 (1993) 401-404.
23. A. Vogel, W. Fürst, M.A. Abo-Hashish, M. Lee-Vaupel, E. Conzelmann, K. Sandhoff, Identify of the activator proteins for the enzymatic hydrolysis of sulfatide, ganglioside GM1, and globotriaosylceramide, Arch. Biochem. Biophys 259 (1987) 627-638.
24. G. Wilkening, T. Linke, G. Uhlhorn-Dierks, K. Sandhoff, Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP, J. Biol. Chem 275 (2000) 35814-35819.
25. J.K. Brukhardt, S. Hüttler, A. Klein, W. Möbius, A. Habermann, G. Griffiths, K. Sandhoff, Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor, Eur. J. Cell. Biol 73 (1997) 10-18.
26. E. Conzelmann, M. Lee-Vaupel, K. Sandhoff, R. Salvayre, L. Douste-Blazy, S. Gatt (Eds.), Lipid Storage Disorders, Plenum Publishing Corporation, New York, 1988, pp. 323-332.
27. S.C. Li, H. Kihara, S. Serizawa, Y.T. Li, A.L. Fluharty, J.S. Mayes, L.J. Shapiro, Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identify with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide, J. Biol. Chem 260 (1985) 1867-1871.
28. S.I. Hakomori, Glycosphingolipids as differentiation-dependent, tumor-associated markers and as regulators of cell proliferation, Trends Biochem. Sci 9 (1984) 453-458.
29. R.K. Yu, R.W. Ledeen, Gangliosides of human, bovine, and rabbit plasma, J. Lipid Res 13 (1972) 680-686.
30. G. Schwarzmann, A simple and novel method for tritium labeling of gangliosides and other sphingolipids, Biochem. Biophys. Acta 529 (1978) 106-114.
31. G. Van Echten, H. Iber, H. Stotz, A. Takatsuki, K. Sandhoff, Uncoupling of ganglioside biosynthesis by Brefeldin A, Eur. J. Cell Biol. 51 (1990) 135-139.
32. H.F. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem 72 (1976) 248-254.
33. G. Legler, Mechanism of action of glycoside-splitting enzymes. V. Labelling of the active center of beta-glucosidases A and B from sweet almond emulsin with (3H)6-bromo-6-deoxyconduritol B epoxide, Hoppe-Seyler's Z, Physiol. Chem. 351 (1970) 25-31.
34. Y. Yoda, T. Ishibashi, A. Makita, Isolation, characterization, and biosynthesis of Forssman antigen in human lung and lung carcinoma, J. Biochem. (Tokyo) 88 (1980) 1887-1890.
35. M. Hiraiwa, S. Soeda, Y. Kishimoto, J.S. O'Brien, Binding and transport of gangliosides by prosaposin, Proc. Natl. Acad. Sci. USA 89 (1992) 11254-11258.
36. M. Henseler, A. Klein, G.J. Glombitza, K. Suzuki, K. Sandhoff, Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system, J. Biol. Chem 271 (1996) 8416-8423.
37. J. Matsuda, M.T. Vanier, Y. Saito, J. Tohyama, K. Suzuki, K. Suzuki, A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse, Hum. Mol. Genet 10 (2001) 1191-1199.
38. B. Schmid, B.C. Paton, K. Sandhoff, K. Harzer, Metabolism of GM1 ganglioside in cultured skin fibroblasts: Anomalies in gangliosides, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders, Hum. Genet 89 (1992) 513-518.
39. L.J. Shapiro, K.A. Aleck, M.M. Kaback, H. Itabashi, R.J. Desnick, N. Brand, R.L. Stevens, A.L. Fluharty, H. Kihara, Metachromatic leukodystrophy without arylsulfatase A deficiency, Pediatr. Res 13 (1979) 1179-1181.
40. B. Paton, B. Schmid, B. Kustermann-Kuhn, A. Poulos, K. Harzer, Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase, Biochem. J. 285 (1992) 481-488.
41. R. Fingerhut, G.T. Van Der Horst, F.W. Verheijen, E. Conzelmann, Degradation of gangliosides by the lysosomal sialidase requires an activator protein, Eur. J. Biochem 208 (1992) 623-629.
42. L. Svennerholm, Chromatographic seperation of human brain ganglioside, J. Neurochem 10 (1963) 613-623.